Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8+ T cells during vaccine immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8+ T cells during vaccine immunotherapy ; volume:35 ; number:1 ; day:13 ; month:9 ; year:2016 ; pages:1-16 ; date:12.2016
Journal of experimental & clinical cancer research ; 35, Heft 1 (13.9.2016), 1-16, 12.2016
- Creator
-
Takeda, Yohei
- Contributor
-
Azuma, Masahiro
Matsumoto, Misako
Seya, Tsukasa
SpringerLink (Online service)
- DOI
-
10.1186/s13046-016-0416-x
- URN
-
urn:nbn:de:1111-201610142196
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takeda, Yohei
- Azuma, Masahiro
- Matsumoto, Misako
- Seya, Tsukasa
- SpringerLink (Online service)
Other Objects (12)
Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
Regulation of Antigen‐Specific Immunotherapy with Nanomaterials
Influence of oral boost immunizations with recombinant Salmonella vaccine strains on the antigen-specific CD8 T-cell induction
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
MHC-based detection of antigen-specific CD8+ T cell responses
Streptamer technology allows to isolate leukemia antigen-specific CD8+ T cells
CD8+ T cell-based cancer immunotherapy
Functional validation of ZEB2/TBKBP1 in antigen-specific CD8⁺ T cell responses
Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence
Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Immunomodulation of antigen-specific CD8+ T-cells by everolimus and mesenchymal stem cells
Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
Regulation of Antigen‐Specific Immunotherapy with Nanomaterials
Influence of oral boost immunizations with recombinant Salmonella vaccine strains on the antigen-specific CD8 T-cell induction
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
MHC-based detection of antigen-specific CD8+ T cell responses
Streptamer technology allows to isolate leukemia antigen-specific CD8+ T cells
CD8+ T cell-based cancer immunotherapy
Functional validation of ZEB2/TBKBP1 in antigen-specific CD8⁺ T cell responses
Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence
Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges
Immunomodulation of antigen-specific CD8+ T-cells by everolimus and mesenchymal stem cells
Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
Regulation of Antigen‐Specific Immunotherapy with Nanomaterials
Influence of oral boost immunizations with recombinant Salmonella vaccine strains on the antigen-specific CD8 T-cell induction
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
MHC-based detection of antigen-specific CD8+ T cell responses
Streptamer technology allows to isolate leukemia antigen-specific CD8+ T cells
CD8+ T cell-based cancer immunotherapy
Functional validation of ZEB2/TBKBP1 in antigen-specific CD8⁺ T cell responses
Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence
Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
Genetically engineered antigen-specific treg cells in immunotherapy: opportunities and challenges